AVX 13616 T14359
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
AVX 13616 shows the potent in vivo antibacterial activity of Avexa�s lead antibacterial candidate; particularly against drug-resistant Staphylococcus pathogens. IC50 value: 2-4 ug/ml (MICs) Target: antibacterial agent AVX13616 was as active as mupirocin i
CAS nr:
900814-48-4
Purity:
98%
Molecular Weight:
955,06
SMILES:
O=C(NC(CCCCN)C(NC(CCCNC(N)=N)C(NC(CC(C)C)C(OCCC(C)C)=O)=O)=O)COC1=C(C(C(C=CC=C2)=C2C=C3)=C3OCCC(C)C)C(C=CC=C4)=C4C=C1.Cl.Cl
Formula:
C50H73Cl2N7O7
Pathway:
Others
Target:
Others
